Individual holder
DOWLING PETER C
US·3 granted patents·2 pending applications·1 citations·filing 2013–2018
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
5 records- 0170US9585932B2Use of EPO-derived peptide fragments for the treatment of neurodegenerative disordersDOWLING PETER C·Filed 2013·Granted Mar 7, 2017·1 cites·2 claims
- 0265US2018303903A1Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic epo short peptidesDOWLING PETER C·Filed 2018·Application pending·0 cites
- 0356US10047132B2Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulatorsDOWLING PETER C·Filed 2017·Granted Aug 14, 2018·0 cites·12 claims
- 0456US9765128B2Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulatorsDOWLING PETER C·Filed 2014·Granted Sep 19, 2017·0 cites·18 claims
- 0545US2017137483A1Use of epo-derived peptide fragments for the treatment of inflammatory diseasesDOWLING PETER C·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DOWLING PETER C files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →